Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alberta Pharmaceutical (China), primarily operating as Jiangsu Alberta Pharmaceutical Co., Ltd., is a pharmaceutical company headquartered in Nanjing, China. The firm specializes in the research, development, manufacturing, and commercialization of high-end generic drugs and innovative small molecule therapeutics. Its product portfolio covers critical therapeutic areas including cardiovascular disease, gastroenterology, and anti-infectives. The company maintains state-of-the-art GMP-certified production facilities to ensure high-quality standards for its domestic and international markets. Alberta Pharmaceutical is committed to improving patient access to essential medicines through continuous innovation and efficient manufacturing processes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alberta Pharmaceutical (China).